| # | Drug | Count |
|---|---|---|
| 0 | PIRFENIDONE | 20 |
| 1 | VEMURAFENIB | 20 |
| 2 | ADALIMUMAB | 12 |
| 3 | COBIMETINIB | 12 |
| 4 | OMEPRAZOLE MAGNESIUM | 12 |
| 5 | ETANERCEPT | 10 |
| 6 | OMEPRAZOLE | 10 |
| 7 | ALPRAZOLAM | 9 |
| 8 | CALCIUM | 8 |
| 9 | ERGOCALCIFEROL | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COBIMETINIB | 12 | 0.0037 |
| 1 | DAROLUTAMIDE | 1 | 0.0023 |
| 2 | VANDETANIB | 3 | 0.0022 |
| 3 | VEMURAFENIB | 20 | 0.0019 |
| 4 | ECHINACEA ANGUSTIFOLIA, HAMAMMELIS VIRGINIANA, CALCAREA PHOSPHORICA, HYDRASTIS CANADANESIS, SENEGA OFFICINALIS, SILICEA, CONIUM, AURUM MURIATICUM NATRONATUM, CALCAREA CARBONICA, FUCUS VESICULOSUS, LACHESIS MUTUS | 1 | 0.0011 |
| 5 | CERITINIB | 2 | 0.0010 |
| 6 | PIRFENIDONE | 20 | 0.0007 |
| 7 | PREDNISOLONE SODIUM PHOSPHATE | 1 | 0.0006 |
| 8 | TERBINAFINE HYDROCHLORIDE | 6 | 0.0005 |
| 9 | MILK THISTLE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 29 |
| 1 | Corticosteroid [EPC] | 23 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 3 | Pyridone [EPC] | 20 |
| 4 | Benzodiazepine [EPC] | 13 |
| 5 | Proton Pump Inhibitor [EPC] | 13 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 10 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 8 | Azole Antifungal [EPC] | 9 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyridone [EPC] | 20 | 0.0007 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 5 | 0.0002 |
| 2 | Tetracycline-class Drug [EPC] | 7 | 0.0002 |
| 3 | Antidote [EPC] | 1 | 0.0001 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 5 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 3 | 0.0001 |
| 6 | Azole Antifungal [EPC] | 9 | 0.0001 |
| 7 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 4 | 0.0001 |
| 8 | Kinase Inhibitor [EPC] | 29 | 0.0001 |
| 9 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 5 | 0.0001 |